Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

875 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Self- versus clinician-collected swabs in anal cancer screening: A clinical trial.
Dyer CEF, Jin F, Roberts JM, Poynten IM, Farnsworth A, McNally LP, Cunningham PH, Grulich AE, Hillman RJ. Dyer CEF, et al. Among authors: cunningham ph. PLoS One. 2025 Jan 9;20(1):e0312781. doi: 10.1371/journal.pone.0312781. eCollection 2025. PLoS One. 2025. PMID: 39787107 Free PMC article. Clinical Trial.
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia.
Applegate TL, Causer LM, Gow I, Alternetti N, Anderson L, Borgnolo B, Cooney L, Cunningham P, Fernando M, Hengel B, Huang RL, Kayago K, King JM, Lew HJ, Martinello M, Milic M, Miller K, O'Connor S, Patel P, Phillips E, Rawlinson W, Sharma A, Shephard MDS, Tangey A, Smith K, Williams AL, Andrewartha K, Guy R, Matthews SJ. Applegate TL, et al. Among authors: cunningham p. Expert Rev Mol Diagn. 2024 Dec 24:1-14. doi: 10.1080/14737159.2024.2403091. Online ahead of print. Expert Rev Mol Diagn. 2024. PMID: 39719681 Free article. Review.
Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey.
Maher L, Wand H, Heard S, Starr M, Zolala F, Kemp R, Cunningham P, Drummer H, Hellard M, Kaldor J, Dore G. Maher L, et al. Among authors: cunningham p. Int J Drug Policy. 2024 Sep 30:104576. doi: 10.1016/j.drugpo.2024.104576. Online ahead of print. Int J Drug Policy. 2024. PMID: 39353802 Free article.
Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey.
Maher L, Wand H, Heard S, Starr M, Zolala F, Kemp R, Cunningham P, Drummer H, Hellard M, Kaldor J, Dore G. Maher L, et al. Among authors: cunningham p. Int J Drug Policy. 2024 Aug 18;131:104545. doi: 10.1016/j.drugpo.2024.104545. Online ahead of print. Int J Drug Policy. 2024. PMID: 39159531
875 results